Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China

被引:41
作者
Zhang, Min [1 ]
Zhang, Nan [2 ]
机构
[1] Shandong Univ, Jinan Cent Hosp, Dept Dermatol, Jinan, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan 250012, Peoples R China
来源
PATIENT PREFERENCE AND ADHERENCE | 2017年 / 11卷
关键词
alopecia; quality of life; People's Republic of China; PSORIASIS; WOMEN; MODERATE; MILD;
D O I
10.2147/PPA.S121218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: In medical terms, alopecia is considered a relatively mild dermatological condition that nevertheless is a serious condition, but it causes major depression in many sufferers. Alopecia areata (AA) and androgenetic alopecia (AGA) are the main types of hair loss. This study assessed the quality of life (QoL) of Chinese patients with AA and AGA using the Dermatology Life Quality Index (DLQI) questionnaire. Methods: A total of 178 AA and AGA patients were enrolled in this study, and DLQI was used to evaluate the QoL of the patients. The DLQI used 10 items regarding symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment as dimensions of life. Each was scored on a 0-3 scale. The total DLQI score equaled 0-30; higher scores showed greater impact on QoL. Results: The DLQI scores of the 178 patients ranged from 0 to 28, with a mean score of 6.3. Higher DLQI scores were reported by younger patients (P, 0.05) and by those who had hair loss for a duration of. 12 months (P, 0.05). The DLQI score of AA patients was significantly higher than that of AGA patients (P, 0.05). QoL was not affected by gender, marital status, educational level, past history of alopecia, family history of alopecia, or severity of alopecia. Conclusion: AA and AGA moderately affected the QoL of the patients. A higher DLQI score was significantly associated with younger age, hair loss for a duration of. 12 months, and AA. Both AA and AGA moderately affected the QoL of the patients not only in physiological aspects but also in their emotional and social aspects. The bio-psycho-social aspects of disease need to be addressed in patients with AA and AGA, even though these conditions are not lifethreatening.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 16 条
[1]   Quality of life measures in psoriasis: a critical appraisal of their quality [J].
Ashcroft, DM ;
Po, ALW ;
Williams, HC ;
Griffiths, CEM .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (05) :391-398
[2]   Illness perceptions, coping and quality of life in patients with alopecia [J].
Cartwright, T. ;
Endean, N. ;
Porter, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (05) :1034-1039
[3]   PSYCHOLOGICAL EFFECTS OF ANDROGENETIC ALOPECIA ON WOMEN - COMPARISONS WITH BALDING MEN AND WITH FEMALE CONTROL SUBJECTS [J].
CASH, TF ;
PRICE, VH ;
SAVIN, RC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (04) :568-575
[4]   Development of a health-related quality of life questionnaire for women with androgenetic alopecia [J].
Dolte, KS ;
Girman, CJ ;
Hartmaier, S ;
Roberts, J ;
Bergfeld, W ;
Waldstreicher, J .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (08) :637-642
[5]   Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf [J].
Erol, Ozgul ;
Can, Gulbeyaz ;
Aydiner, Adnan .
SUPPORTIVE CARE IN CANCER, 2012, 20 (10) :2349-2356
[6]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216
[7]   The role of psychological factors in alopecia areata and the impact of the disease on the quality of life [J].
Gülec, AT ;
Tanriverdi, N ;
Dürü, Ç ;
Saray, Y ;
Akçali, C .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (05) :352-356
[8]   Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study [J].
Han, Sung-Hyub ;
Byun, Ji-Won ;
Lee, Won-Soo ;
Kang, Hoon ;
Kye, Yong-Chul ;
Kim, Ki-Ho ;
Kim, Do-Won ;
Kim, Moon-Bum ;
Kim, Seong-Jin ;
Kim, Hyung-Ok ;
Sim, Woo-Young ;
Yoon, Tae-Young ;
Huh, Chang-Hun ;
Hwang, Seung-Sik ;
Ro, Byung-In ;
Choi, Gwang-Seong .
ANNALS OF DERMATOLOGY, 2012, 24 (03) :311-318
[9]  
Helms Rebecca L, 2008, Psychol Health Med, V13, P313, DOI 10.1080/13548500701405509
[10]   Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? [J].
Krueger, GG ;
Feldman, SR ;
Camisa, C ;
Duvic, M ;
Elder, JT ;
Gottlieb, AB ;
Koo, J ;
Krueger, JG ;
Lebwohl, M ;
Lowe, N ;
Menter, A ;
Morison, WL ;
Prystowsky, JH ;
Shupack, JL ;
Taylor, JR ;
Weinstein, GD ;
Barton, TL ;
Rolstad, T ;
Day, RM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (02) :281-285